|
|
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
Methods and compositions are provided for labeling T cells according to the specificity of their antigen receptor. A stable multimeric complex is prepared with major ...
|
|
|
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
OF THE PREFERRED EMBODIMENTS According to one aspect of the present invention, a nonapeptide (9 amino acid peptide) of the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID ...
|
|
|
CTL epitope analogs
Accordingly, this invention comprises a method of producing a human cytomegalovirus peptide cytotoxic T lymphocyte epitope analog with improved immunogenic potency and ...
|
|
|
HCMV-reactive T cells and uses therefor
OF THE PREFERRED EMBODIMENTS A nonapeptide having the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID NO:1) is an immunogenic epitope of pp65 from CMV laboratory strains A...
|
|
|
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
Accordingly, one aspect of the present invention relates to immunologically active peptides, and functional variants thereof, capable of eliciting a cellular immune ...
|
|
|
Synthetic peptide having an ionophoric and antimicrobial activity
OF THE INVENTION Synthetic peptide P1 of the present invention is comprised by 26 amino acids. The natural existence of this peptide in bacteria and animals has not ...
|
|
|
Anti-TNF antibodies and peptides of human tumor necrosis factor
It is the object of the present invention to overcome one or more deficiencies of the background art. It is also an object of the present invention to provide methods ...
|
|
|
Rod-coil block polyimide copolymers
What is claimed is: 1. Rod-coil block copolymers having polyimide rod segments alternating with polyether coil segments derived from the reaction of approximately 20 to 5...
|
|
|
System to detect protein-protein interactions
These and other objects are achieved by the present invention which provides a method and a kit for detecting interactions between proteins, in vivo, using ...
|
|
|
Production of antibodies from transgenic animals
We claim: 1. A transgenic mouse which has had inserted into its genome DNA comprising human Vh, human Dh, human Jh segments and human mu segments of human ...
|